European markets ended the day mixed after U.S. data weighed on indices.

U.S. data released today showed that consumer prices rose at the fastest pace in more than three years in April. According to the data prices rose 0.4% last month, driven by a surge in gas prices. However, consumer prices rose just 1.1% over the past 12 months.

The FTSE 100 reached a two-week high today, closing 0.3% up at 6,167.77.

Taylor Wimpey pulled up the index, closing 4.38% up. The homebuilder today raised its operating margin guidance for the next three years and said it would pay £1.3 billion ($1.9 billion) in dividends over the period.

Vodafone (VOD) ended the day 1.52% up at 227.07 pence, after predicting Ebitda growth would accelerate to between 3% and 6% this year.

In Frankfurt, the Dax closed down 0.63% at 9,890.19. In Paris, the Cac 40 lost 0.34% to close at 4,297.57.

Car makers weighed down European indices on Tuesday, as HSBC Holdings downgraded the auto sector to underweight from neutral.

Fiat Chrysler (FIATY) was down almost 6.67% after BNP Paribas downgraded the stock to underperform because it hasn't taken enough steps to protect itself against a downturn in the car market.

Peugeot (PUGOY) shares were down more than 4% in Paris.

Daimler (DDAIY) lost 1.33%; BMW (BAMXY) ended the day 3% down and Volkswagen (VLKAY) closed 2.67% down.

More from Markets

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant